SGMT

NASDAQStock

Sagimet Biosciences Inc.

$5.21-0.14 (-2.53%)

52-Week Range

$1.90
$10.24

Key Stats

Market Cap

P/E Ratio

Dividend Yield

Beta

3.40

Volume

326.2K

Avg Volume

322.8K

Performance

1M

+3.69%

3M

-11.44%

6M

-16.04%

YTD

-10.85%

1Y

+42.78%

3Y

-66.52%

5Y

-66.52%

Price Chart

ETF Exposure

SGMT is held by 18 ETFs

ETFFund NameWeight
IWCiShares Micro-Cap ETF0.04%
IBBQInvesco Nasdaq Biotechnology ETF0.01%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.01%
AVSCAvantis U.S. Small Cap Equity ETF0.01%
IBBiShares Biotechnology ETF0.01%
BIBProShares - Ultra Nasdaq Biotechnology0.01%
DFASDimensional - US Small Cap ETF0.00%
VXFVanguard Extended Market ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
DFSUDimensional - US Sustainability Core 1 ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About SGMT ETF Exposure

Sagimet Biosciences Inc. (SGMT) is held by 18 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $5.21. Investors can gain exposure to SGMT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SGMT, sorted by portfolio weight.